Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ACTAVIS LABS FL INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 57
  • 0 comments

FDA approve KETOPROFEN

Comment Full text

TARO PHARM INDS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 40
  • 0 comments

FDA approve ETODOLAC

Comment Full text

APOTEX INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 55
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

AMICI PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 50
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

DR REDDYS LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 49
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

RK PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 60
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

APOTEX INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 55
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

TEVA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 50
  • 0 comments

FDA approve ETODOLAC

Comment Full text

PADAGIS US

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 56
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

ACTAVIS MID ATLANTIC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 54
  • 0 comments

FDA approve IBUPROFEN

Comment Full text
  • Previous
  • 296
  • 297
  • 298
  • 299
  • 300
  • Next

Search

News categories

  • Technical Exchange News(14634)
  • Event(6229)
  • SEC News(388519)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(236998)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin